Search Results - "Sh. I. Musin"

Level of tumor-infiltrating lymphocytes and PD status as potential prognostic markers of survival and therapy effectiveness in triple-negative breast cancer by Nasretdinov, A. F., Sultanbaeva, N. I., Musin, Sh. I., Pushkarev, A. V., Menshikov, K. V., Pushkarev, V. A., Sultanbaev, A. V.

“…In breast cancer, genetic profile and expression of immunohistochemical markers determine prognosis and treatment scheme. Triple-negative breast cancer is…”
Get full text

Comparative analysis of resection boundaries depending on the defect elimination method in oral mucosal cancer by Musin, Sh. I., Menshikov, K. V., Sultanbayev, A. V., Sharifgaleev, I. A., Ilyin, V. V., Guz, A. O., Rudyk, A. N., Osokin, S. V., Sharafutdinova, N. A., Chashchin, A. V., Garev, A. V., Baymuratov, T. R.

“…   Introduction.  Surgical intervention remains the main method for treatment of the oral mucosa cancer. The generally accepted standard of the resection…”
Get full text

Possible applications for combined lenvatinib and pembrolizumab in advanced endometrial carcinoma by Menshikov, K. V., Sultanbaev, A. V., Musin, Sh. I., Menshikova, I. A., Sultanbaeva, N. I., Izmailov, A. A., Fatikhova, A. A., Lipatov, D. O., Serebrennikov, G. A.

“…Endometrial cancer is one of the most common gynaecological cancers in both the United States and the Russian Federation, and the rate continues to rise…”
Get full text

Breast cancer screening in germline mutation carriers. A literature review by Sultanbaev, A. V., Nasretdinov, A. F., Galeev, M. G., Menshikov, K. V., Musin, Sh. I., Sultanbaeva, N. I., Ayupov, R. T., Rakhimov, R. R., Lipatov, O. N., Izmaylov, A. A., Menshikova, I. A., Serebrennikov, G. A., Lipatov, D. O.

“…Carriers of germline mutations have an increased risk of developing malignant neoplasms. Mutations in the BRCA1/2 gene are the most studied, leading to an…”
Get full text

Clinical case of surgical treatment of advanced basal cell carcinoma of the skin on the face by Sharafutdinova, N. A., Musin, Sh. I., Sultanbayev, A. V., Menshikov, K. V., Ilyin, V. V., Ibragimov, B. A., Izmailov, A. A., Sharifgaliev, I. A., Zainullin, F. D.

“…Introduction. Basal cell carcinoma is the most common type of non-melanocytic malignant tumors of the skin. The main treatment methods for this pathology are…”
Get full text

Immune Checkpoint Inhibitors in Urothelial Carcinoma (Literature Review) by Menshikov, K. V., Sultanbaev, A. V., Musin, Sh. I., Izmailov, A. A., Lipatov, O. N., Menshikova, I. A., Sultanbaeva, N. I., Popova, E. V.

“…Bladder cancer is globally considered as one of the most aggressive neoplasms. Traditionally, first-line therapy for metastatic urothelial carcinoma has…”
Get full text

Hepatocellular Carcinoma: Aetiology and Mechanisms of Development. A Literature Review by Menshikov, K. V., Sultanbaev, A. V., Musin, Sh. I., Rakhmatullina, I. R., Menshikova, I. A., Abdeev, R. R., Sultanbaeva, N. I., Popova, E. V., Serebrennikov, G. A.

“…Liver cancer remains a global challenge of healthcare, with the incidence growing worldwide. According to various authors, over 1 million patients will be…”
Get full text

Immunotherapy of advanced hepatocellular carcinoma: case report and literature review by Menshikov, K. V., Sultanbaev, A. V., Musin, Sh. I., Menshikova, I. A., Abdeev, R. R., Sultanbaeva, N. I., Nigmatullin, V. G., Popova, E. V.

“…Hepatocellular carcinoma is a common type of liver malignancy and one of the leading causes of cancer death worldwide. In the Russian Federation, according to…”
Get full text

Efficacy of the 1st generation tyrosine kinase inhibitor sunitinib in the treatment of metastatic renal cell carcinoma in alternative dosing regimens by Menshikov, K. V., Sultanbaev, A. V., Musin, Sh. I., Izmailov, A. A., Chalov, V. S., Menshikova, I. A., Sultanbaeva, N. I., Popova, E. V., Lipatov, D. O.

“…Metastatic renal cell carcinoma accounts for almost 85% of all cases of malignant neoplasms of the kidney. Sunitinib is an anti-angiogenic tyrosine kinase…”
Get full text

Oropharyngeal cancer diagnosis and treatment in actual clinical practice in the Republic of Bashkortostan: analysis for 2020 by Musin, Sh. I., Sultanbaev, A. V., Menshikov, K. V., Zakirova, L. K., Mufazalov, F. F., Sharifgaliev, I. A., Nasretdinov, A. F., Osokin, S. V., Sharafutdinova, N. A., Ilyin, V. V., Lipatov, D. O., Sultanbaev, M. V., Timin, T. E.

“…Introduction. Th e growing incidence of oropharyngeal cancer is driven by an increase in frequency of HPV-associated oropharyngeal cancer. Th e morbidity…”
Get full text

Prospects of PARP Inhibitors in Treatment of BRCA-Mutated Pancreatic Cancer: a Literature Review by Menshikov, K. V., Sultanbaev, A. V., Musin, Sh. I., Izmailov, A. A., Menshikova, I. A., Sultanbaeva, N. I., Popova, E. V., Khammatova, L. A.

“…Pancreatic adenocarcinoma has a  5-year overall survival rate of 9 %, with an outlook of becoming the second leading cause of cancer mortality in the USA by…”
Get full text

Surgical stage in sequential therapy of unresectable oral cancer T3-4bN0-3M0: evaluation of treatment results by Musin, Sh. I., Sultanbayev, A. V., Menshikov, K. V., Mufazalov, F. F., Nasretdinov, A. F., Goncharova, O. V., Osokin, S. V., Zamilov, M. M., Timin, K. E.

“…Introduction . Unresectable oral cancer is an urgent and complex problem in modern oncology. Annually, the proportion of patients with stage III–IV is 35 %,…”
Get full text

Clinical case of the treatment of metastatic luminal breast cancer by Nasretdinov, A. F., Sultanbaev, A. V., Menshikov, K. V., Musin, Sh. I., Sultanbaeva, N. I., Izmailov, A. A., Ayupov, R. T.

“…Hormone therapy currently open up the prospect of long-term, comfortable and relatively low-toxic treatment for patients with hormone receptor – positive…”
Get full text

Metastatic renal cell carcinoma, the possibility of targeted therapy. Case by Menshikov, K. V., Izmailov, A. A., Sultanbaev, A. V., Musin, Sh. I., Chalov, V. S., Menshikova, I. A., Sultanbaeva, N. I., Lipatov, D. O.

“…Malignant neoplasms of the kidney are quite an urgent problem. In the Russian Federation in 2019, 20758 patients with a newly diagnosed renal cell carcinoma…”
Get full text

Neuroendocrine Tumours: a Literature Review by Menshikov, K. V., Sultanbaev, A. V., Musin, Sh. I., Menshikova, I. A., Nasretdinov, A. F., Sultanbaeva, N. I., Shaykhutdinov, I. R.

“…Neuroendocrine tumours (NETs) are a heterogeneous group of malignant neoplasms with diverse morphology and nomenclature. Well-differentiated NETs were…”
Get full text

Optimal solutions in the third line therapy for refractory metastatic colorectal cancer. CORRECTness and CONCURency by Ayupov, R. T., Izmailov, A. A., Menshikov, K. V., Sultanbaev, A. V., Nasretdinov, A. F., Rakhimov, R. R., Musin, Sh. I., Sultanbaeva, N. I.

“…Colon cancer therapy currently includes at least 3 cytostatic agents and 6 targeted drugs, combinations of which constitute many different treatment regimens…”
Get full text

Hedgehog inhibitor in the treatment of basal cell skin cancer: case report by Musin, Sh. I., Sharafutdinova, N. А., Sultanbaev, A. V., Osokin, S. V., Ibragimov, B. A., Menshikov, K. V., Ayupov, R. T.

“…Background. In the structure of malignant neoplasms, basal cell skin cancer (BCC) occupies a leading position. In the initial stages of a malignant neoplasm,…”
Get full text

Inhibitors of cyclin-dependent kinases 4/6 for breast cancer patients with different somatic mutations of the PIK3CA gene by Nasretdinov, A. F., Sultanbaeva, N. I., Musin, Sh. I., Lipatov, O. N., Izmailov, A. A., Ayupov, R. T., Menshikov, K. V., Pushkarev, A. V., Sultanbaev, A. V.

“…Introduction. Breast cancer is the leader in cancer incidence in theRussian Federation. The tumor is considered extremely heterogeneous and the luminal…”
Get full text

Experience of targeted therapy for ALK positive non-small cell lung cancer – a clinical case by Sultanbaev, A. V., Musin, Sh. I., Menshikov, K. V., Nasretdinov, A. F., Ibragimov, B. A., Nigmatullin, A. G., Ayupov, R. T., Izmailov, A. A., Sultanbaeva, N. I.

“…Lung cancer holds a leading position in the cancer mortality pattern worldwide. The emergence of knowledge about driver mutations heralded a new era in the…”
Get full text

Multilineal treatment strategy of HER2-positive metastatic breast cancer (clinical case) by Nasretdinov, A.   F., Pushkarev, A.   V., Lipatov, O.  N. , Sultanbaeva, N.   I., Musin, Sh.   I., Menshikov, K.   V., Izmailov, A.   A., Pushkarev, V.   A., Galeev, M.   G., Muginov, R.   R., Valiakhmedov, R.   B., Sakaeva, D.   D., Sultanbaev, A.   V.

“…Descripton of metastatic HER2-positive breast cancer clinical case is introduced, multilineal strategy basing on clinical situation and disease features is…”
Get full text